47th Annual RSA Scientific Meeting: June 22–26, 2024, Minneapolis, MN

DOI: https://doi.org/10.1111/acer.15315

2024-06-04

Alcoholism Clinical and Experimental Research

Abstract:Alcohol, Clinical and Experimental Research, Volume 48, Issue S1, Page 4-10, June 2024.

substance abuse

What problem does this paper attempt to address?

Texas Research Society On Alcoholism—34Th Annual Scientific Meeting

DOI: https://doi.org/10.1111/acer.15320

2024-06-04

Alcoholism Clinical and Experimental Research

Abstract:Alcohol, Clinical and Experimental Research, Volume 48, Issue S1, Page 546-551, June 2024.

substance abuse
Summary of poster abstract

DOI: https://doi.org/10.1111/acer.15317

2024-06-04

Alcoholism Clinical and Experimental Research

Abstract:Alcohol, Clinical and Experimental Research, Volume 48, Issue S1, Page 142-145, June 2024.

substance abuse
Emerging concepts in alcohol, infection & immunity: A summary of the 2023 alcohol and immunology research interest group (AIRIG) meeting

Lauren N Rutt,Mengfei Liu,Esther Melamed,Shannon Twardy,Jamie L Sturgill,Lisa A Brenner,Josiah Hardesty,Steven A Weinman,Madison M Tschann,Jared Travers,David A Welsh,Natalie Chichetto,Kathryn M Crotty,Bryan Mackowiak,Samantha M Yeligar,Todd A Wyatt,Rachel H McMahan,Mashkoor A Choudry,Elizabeth J Kovacs,Rebecca L McCullough

DOI: https://doi.org/10.1016/j.alcohol.2024.04.002

IF: 2.558

Alcohol

Abstract:On December 8th 2023, the annual Alcohol and Immunology Research Interest Group (AIRIG) meeting was held at the University of Colorado Anschutz Medical Campus in Aurora, Colorado. The 2023 meeting focused broadly on how acute and chronic alcohol exposure leads to immune dysregulation, and how this contributes to damage in multiple tissues and organs. These include impaired lung immunity, intestinal dysfunction, autoimmunity, the gut-Central Nervous System (CNS) axis, and end-organ damage. In addition, diverse areas of alcohol research covered multiple pathways behind alcohol-induced cellular dysfunction, including inflammasome activation, changes in miRNA expression, mitochondrial metabolism, gene regulation, and transcriptomics. Finally, the work presented at this meeting highlighted novel biomarkers and therapeutic interventions for patients suffering from alcohol-induced organ damage.
Alcohol and Immunology: Mechanisms of multi-organ damage. Summary of the 2022 alcohol and Immunology research interest group (AIRIG) meeting

Rachel H McMahan,Paige Anton,Leon G Coleman,Gail A M Cresci,Fulton T Crews,Kathryn M Crotty,Marisa E Luck,Patricia E Molina,Vidula Vachharajani,Joanne Weinberg,Samantha M Yeligar,Mashkoor A Choudhry,Rebecca L McCullough,Elizabeth J Kovacs

DOI: https://doi.org/10.1016/j.alcohol.2023.04.002

IF: 2.558

Alcohol

Abstract:On October 26th, 2022 the annual Alcohol and Immunology Research Interest Group (AIRIG) meeting was held as a satellite symposium at the annual meeting of the Society for Leukocyte Biology in Hawaii. The 2022 meeting focused broadly on the immunological consequences of acute, chronic, and prenatal alcohol exposure and how these contribute to damage in multiple organs and tissues. These included alcohol-induced neuroinflammation, impaired lung immunity, intestinal dysfunction, and decreased anti-microbial and anti-viral responses. In addition, research presented covered multiple pathways behind alcohol-induced cellular dysfunction, including mitochondrial metabolism, cellular bioenergetics, gene regulation, and epigenetics. Finally, the work presented highlighted potential biomarkers and novel avenues of treatment for alcohol-induced organ damage.
Stress-Related Neuropeptides and Alcoholism: Crh, Npy, and Beyond

Roberto Ciccocioppo,Donald R. Gehlert,Andrey Ryabinin,Simranjit Kaur,Andrea Cippitelli,Annika Thorsell,Anh D. Le,Philip A. Hipskind,Chafiq Hamdouchi,Jianliang Lu,Erik J. Hembre,Jeffrey Cramer,Min Song,David McKinzie,Michelle Morin,Daina Economidou,Serena Stopponi,Nazzareno Cannella,Simone Braconi,Marsida Kallupi,Giordano de Guglielmo,Maurizio Massi,David T. George,Jody Gilman,Jacqueline Hersh,Johannes T. Tauscher,Stephen P. Hunt,Daniel Hommer,Markus Heilig

DOI: https://doi.org/10.1016/j.alcohol.2009.08.003

IF: 2.558

2009-01-01

Alcohol

Abstract:This article summarizes the proceedings of a symposium held at the conference on “Alcoholism and Stress: A Framework for Future Treatment Strategies” in Volterra, Italy, May 6–9, 2008. Chaired by Markus Heilig and Roberto Ciccocioppo, this symposium offered a forum for the presentation of recent data linking neuropetidergic neurotransmission to the regulation of different alcohol-related behaviors in animals and in humans. Dr. Donald Gehlert described the development of a new corticotrophin-releasing factor receptor 1 antagonist and showed its efficacy in reducing alcohol consumption and stress-induced relapse in different animal models of alcohol abuse. Dr. Andrey Ryabinin reviewed recent findings in his laboratory, indicating a role of the urocortin 1 receptor system in the regulation of alcohol intake. Dr. Annika Thorsell showed data supporting the significance of the neuropeptide Y receptor system in the modulation of behaviors associated with a history of ethanol intoxication. Dr. Roberto Ciccocioppo focused his presentation on the nociceptin/orphanin FQ (N/OFQ) receptors as treatment targets for alcoholism. Finally, Dr. Markus Heilig showed recent preclinical and clinical evidence suggesting that neurokinin 1 antagonism may represent a promising new treatment for alcoholism. Collectively, these investigators highlighted the significance of neuropeptidergic neurotransmission in the regulation of neurobiological mechanisms of alcohol addiction. Data also revealed the importance of these systems as treatment targets for the development of new medication for alcoholism.
Abstract LB143: Environmental assessment of alcohol-related policies and practices at US cancer organizations

Meghan Si,Stephanie Martch,Sanjay Shete,Ernest Hawk

DOI: https://doi.org/10.1158/1538-7445.am2024-lb143

IF: 11.2

2024-04-07

Cancer Research

Abstract:In 1998, the International Agency for Research on Cancer (IARC) declared that the consumption of alcoholic beverages was a class I carcinogen to humans; the designation was reaffirmed in 2007 and 2010. Despite this, approximately 4% of new cancer cases worldwide in 2020 were attributable to alcohol intake. Growing evidence indicates that alcohol use increases the risk of cancers of the upper aerodigestive tract (oral cavity, pharynx, esophagus, and larynx) and lower digestive tract (colon, rectum, and liver). Over half of the 6.3 million cases of these cancers are considered preventable, underscoring notable gaps regarding alcohol consumption and cancer prevention. Despite (1) the longstanding designation of alcohol as an established carcinogen, (2) an increasing and consistent body of data noting alcohol as a leading contributor to the global cancer burden, and (3) the publication of policy statements by authoritative sources, it is unclear whether cancer-focused institutions are aware of these facts or are acting on these data (i.e., implementing evidence-based policies and practices to limit alcohol-related cancer risks for their employees, guests, or the public). Driven by these data and shortfalls, we developed a 22-item survey to inquire about cancer organizations' interpretation of current literature, existing policies, decision-making processes, inclination to act, and perceived responsibility to lead in the realms of public education and policy implementation to mitigate alcohol-related cancer risks in the public's interest. The survey will be sent to over 100 leading U.S. cancer organizations, including NCI-designated- and other major cancer centers, cancer-oriented professional organizations, and cancer-research organizations. It underwent rigorous testing for clarity, brevity, and expected response time, also drawing upon the expertise of five survey-science professionals. The study is under institutional review board (IRB) review, and we anticipate the survey's distribution in the first quarter of the calendar year 2024. We expect to share the survey instrument and results during the meeting. Citation Format: Meghan Si, Stephanie Martch, Sanjay Shete, Ernest Hawk. Environmental assessment of alcohol-related policies and practices at US cancer organizations [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 2 (Late-Breaking, Clinical Trial, and Invited s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(7_Suppl) nr LB143.

oncology
BASHH Annual Conference 2024, Bournemouth, UK, June 17–19 2024

DOI: https://doi.org/10.1177/09564624241254949

2024-06-15

International Journal of STD & AIDS

Abstract:International Journal of STD &AIDS, Volume 35, Issue 1_suppl, Page 1-157, June 2024.

immunology,infectious diseases
Proceedings of the 2024 Spring Meeting of the Society of British Neurological Surgeons

DOI: https://doi.org/10.1080/02688697.2024.2354094

2024-06-02

British Journal of Neurosurgery

Abstract:This meeting was hosted by the Royal Infirmary, Edinburgh 17th–19th April 2024 at The Edinburgh International Conference Centre, Edinburgh. The full abstracts of the platform presentations are followed by the titles of those submissions accepted as short orals and e-posters. The order of abstracts is that of presentation. Any papers in the programme that were not presented to the society at the meeting have not been published.

surgery,clinical neurology
Impact of Acute Alcohol Consumption on Sexuality: A Look at Psychological Mechanisms

William H George,Jessica A Blayney,Kelly Cue Davis,William H. George,Jessica A. Blayney

DOI: https://doi.org/10.1146/annurev-clinpsy-080921-075423

IF: 22.098

2024-02-12

Annual Review of Clinical Psychology

Abstract:Alcohol's link with sexuality is long-standing and prominent. While research continues to document robust associations between drinking and sexual behavior, attention now centers primarily on evaluating mechanisms and attendant theoretical frameworks to advance our understanding of how alcohol exerts a causal impact. We describe four domains with reliable evidence of alcohol effects: sexualized social perceptions, sexual arousal, sexual risk taking, and sexual assault. We consider three contextual frames: distal factors associated with encountering opportunities for alcohol-involved sex, proximal factors associated with alcohol's acute effects, and distal–proximal interactions. We then examine the empirical support for mechanisms embedded within four theoretical frameworks: alcohol disinhibition, alcohol expectancy, alcohol myopia, and emotion regulation. Support for disinhibition mechanisms is evident with sexual arousal only. Expectancy and myopia mechanisms enjoy support across domains and make up bases for integrative expectancy–myopia causal explanations. Emotion regulation mechanisms evidence preliminary support in risk taking and sexual assault. Implications and future directions are considered. Expected final online publication date for the Annual Review of Clinical Psychology, Volume 20 is May 2024. Please see http://www.annualreviews.org/page/journal/pubdates for revised estimates.

psychology, clinical
Proceedings of the 2009 Annual Meeting of the Fetal Alcohol Spectrum Disorders Study Group

Feng C. Zhou,Cynthia J. M. Kane,Susan M. Smith

DOI: https://doi.org/10.1016/j.alcohol.2010.12.008

IF: 2.558

2011-01-01

Alcohol

Abstract:The annual meeting of the Fetal Alcohol Spectrum Disorders Study Group (FASDSG) was held on June 20, 2009 in San Diego, CA, as a satellite of the Research Society on Alcoholism Meeting. The FASDSG membership includes clinical, basic, and social scientists who meet to discuss recent advances and issues in Fetal Alcohol Spectrum Disorders research. The main theme of the meeting was “Epigenetics and Development.” Two keynote speakers, Dr. Randy Jirtle and Dr. Michael Skinner, addressed the role of epigenetics and environmental inputs, including alcohol, during critical stages of development and their potential critical and long-lasting effects. Members of the FASDSG provided new findings through brief “FASt” data reports, and national agency representatives provided updates on activities and funding priorities. Scientific presentations were made by recipients of the Student Research Merit Award and Rosett Award.
S1845 A Cross-Sectional Study of Alcohol Awareness, Consumption Patterns, and Alcohol Related Disease in a Tertiary Center Liver Clinic

Sofi Damjanovska,Jenny Jan,Erica Graff,Daniel Karb,Seth Sclair,Stanley M. Cohen

DOI: https://doi.org/10.14309/01.ajg.0001036748.12985.9f

2024-10-26

The American Journal of Gastroenterology

Abstract:In the past decade in the United States there has been increase in alcohol related economic cost and mortality. We aim to identify alcohol awareness and consumption patterns in patients in liver clinics. Our hypothesis is that patients that lack knowledge of alcohol related complications will consume more alcohol and have alcohol related liver disease (ALD) as etiology of their chronic liver disease more often.

gastroenterology & hepatology
Poster abstracts

DOI: https://doi.org/10.1111/fcp.13017

2024-06-10

Fundamental and Clinical Pharmacology

Abstract:Fundamental &Clinical Pharmacology, Volume 38, Issue S1, Page 94-207, June 2024.

pharmacology & pharmacy
Proceedings of the 2008 Annual Meeting of the Fetal Alcohol Spectrum Disorders Study Group

Jennifer D. Thomas,Feng C. Zhou,Cynthia J.M. Kane

DOI: https://doi.org/10.1016/j.alcohol.2009.04.004

2009-01-01

Abstract:The annual meeting of the Fetal Alcohol Spectrum Disorders Study Group (FASDSG) was held on June 28, 2008 in Washington DC, as a satellite to the Research Society on Alcoholism meeting. The FASDSG membership includes clinical, basic, and social scientists who meet to discuss recent advances and issues in FASD research. The main theme of the meeting was “Factors that Influence Brain and Behavioral Development: Implications for Prevention and Intervention.” Two keynote speakers, Dr. Stephen Suomi and Dr. Carl Keen addressed how early environment and nutrition may influence outcome after prenatal alcohol exposure. The final keynote speaker, Kathy Mitchell, addressed issues regarding the relationship between scientists and the families with children with FASD. Members of the FASDSG provided updates on new findings through brief (FASt) data reports and national agency representatives provided updates of activities and funding priorities. Presentations were also made by recipients of the Student Research Merit award and Rosett award.
68th Annual Meeting of the German Society of Neuropathology and Neuroanatomy (DGNN) - Meeting Abstracts: September 12-14, 2024, Regensburg, Germany

DOI: https://doi.org/10.17879/freeneuropathology-2024-5842

2024-09-03

Abstract:Dear colleagues, It is my pleasure and honor to host the 68th Annual Meeting of the German Society of Neuropathology and Neuroanatomy (DGNN) in Regensburg. Since the Magdeburg meeting in 2019 this is the first pure national meeting of our society that will be held in presence after five long years. While the meeting in 2020 was cancelled due to the Corona pandemic, the 2021 meeting (organized by the colleagues in Gießen) took place as a mere online meeting. In 2022 and 2023 our national society meetings were embedded in the "Neurowoche" and the International Congress of Neuropathology in Berlin. We are enthusiastic about this years' reunion of our society in Regensburg. In our Regensburg meeting, we aim to provide a comprehensive update on the major and hot topics in neuropathology. Neuropathologists address some of the currently most relevant and discussed health care issues, such as for example cancer, neuroimmunological diseases like Multiple Sclerosis, neurodegenerative diseases including Alzheimer's and Parkinson's, and muscle/nerve diseases. As tissue specialists, neuropathologists directly study diseases in human materials. Neuropathologists use state of-the-art methods to uncover disease processes on the molecular level. During our congress, we will hear a lot on the methodical progress made in this regard. Neuropathology is also becoming increasingly clinical as many of our scientific and diagnostic findings influence and directly guide treatment decisions. We were able to attract renowned national and international speakers and our meeting will allow for an intensive interchange both within our society and with our neighboring disciplines. Program highlights include a Pre-Congress hands-on Workshop on Next Generation Sequencing, a session on Molecular Tumorboards and a Mini-Symposium on Quality Assurance in Neuropathology. We are delighted about the submission of 31 abstracts covering the research fields Neurooncology, Neuroimmunology, Muscle/Nerve, Neurodegeneration, and Methods/Free Topics. The abstracts are published below in this edition of Free Neuropathology. I want to thank the scientific committee of our congress for helping in evaluating the submissions and selecting the poster talks and poster spotlight presentations. Many of the abstracts were submitted by our young researchers. They deserve our special attention! Posters will be exhibited throughout the entire congress and we will have plenty of time for poster viewing and discussions on Thursday evening at the Welcome Reception and at the main poster session on Friday at noon. So let me again welcome you all to our beautiful city of Regensburg. I am looking forward to inspiring talks, vivid discussions and enriching encounters with like-minded people. Yours, Prof. Dr. Markus J. Riemenschneider Regensburg University Hospital, Department of Neuropathology Congress President DGNN Annual Meeting 2024.
From AACR 2024

Diana Romero

DOI: https://doi.org/10.1038/s41571-024-00897-9

IF: 78.8

2024-04-26

Nature Reviews Clinical Oncology

Abstract:The American Association for Cancer Research (AACR) Annual Meeting 2024 brought together ~22,000 delegates, either in San Diego or virtually. As the programme committee chairs explained in the opening plenary session, one of the main objectives of this meeting was to highlight how technological advances from the past decade are being integrated into patient care. Promising results were presented in three clinical plenary sessions. In the phase I/II LINKER-MM1 trial, patients with multiple myeloma received the BCMA × CD3 T cell engager linvoseltamab. The objective response rate (ORR) was 71%, including complete responses in 46% of patients. Although 73% of patients had grade 3–4 infections, their frequency and severity decreased after 6 months. In the phase III COMPASSION-15 trial, addition of the PD-1 × CTLA4 bispecific antibody cadonilimab to first-line chemotherapy in patients with gastric and gastro-oesophageal adenocarcinomas improved median overall survival (15 months versus 10.8 months; HR 0.62, 95% CI 0.50–0.78; P < 0.001). Grade ≥3 adverse events occurred in 66% of patients. In the phase I/II PETRA trial, the novel poly(ADP-ribose) polymerase 1-selective inhibitor saruparib was well tolerated in patients with advanced-stage solid tumours. Some efficacy signals were detected, including an ORR of 48% in patients with breast cancer, although longer follow up is needed.

oncology
Participant diversity in ACER: 2010–2022

Heather A. Kissel,Ga Hee Lee,Sara McFarland,Dexton Berger,Elizabeth Enneking,Jenna Dunham,Ty Brumback

DOI: https://doi.org/10.1111/acer.15324

2024-04-24

Alcoholism Clinical and Experimental Research

Abstract:Background Increasing diversity has become a priority for all fields working with human subjects due to historic exclusions and misrepresentations of participants with minoritized identities. To create a more representative and generalizable science of alcohol use, the Research Society on Alcohol (RSA) and its official journal, Alcohol: Clinical and Experimental Research (ACER), have increasingly incorporated diversity and inclusion into their posted values and programming. Methods We analyzed the content of articles published in ACER from 2010 through 2022 (6 years before and after the formation of RSA's Diversity Committee) to assess the reporting of participants' demographic information and whether there has been increased inclusion of diverse samples in alcohol research over time. Our team screened 3292 abstracts for data extraction; studies were included if they were primary analyses of data collected from human subjects (n = 1043). Results Reporting of all demographic variables increased over time, with significant increases in reporting for race/ethnicity, sexual orientation, gender identity, socioeconomic status (SES), income, and educational attainment. Demographic variables were also increasingly used in analyses. However, representation of research outside the United States diminished significantly over time. Conclusions We provide recommended journal article reporting standards for ACER to continue the positive progress in reporting demographics in alcohol research and facilitate meta‐analyses examining demographic modulation and the impact of social determinants of health.

substance abuse
Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting

Matias A Avila,Jean-François Dufour,Alexander L Gerbes,Fabien Zoulim,Ramon Bataller,Patrizia Burra,Helena Cortez-Pinto,Bin Gao,Ian Gilmore,Philippe Mathurin,Christophe Moreno,Vladimir Poznyak,Bernd Schnabl,Gyongyi Szabo,Maja Thiele,Mark R Thursz

DOI: https://doi.org/10.1136/gutjnl-2019-319720

IF: 24.5

2019-12-26

Gut

Abstract:Alcohol-related liver disease (ALD), which includes a range of disorders of different severity and is one of the most prevalent types of liver disease worldwide, has recently regained increased attention. Among other reasons, the realisation that any alcohol intake, regardless of type of beverage represents a health risk, and the new therapeutic strategies tested in recently published or undergoing clinical trials spur scientific interest in this area. In April 2019, Gut convened a round table panel of experts during the European Association for the Study of the Liver International Liver Congress in Vienna to discuss critical and up-to-date issues and clinical trial data regarding ALD, its epidemiology, diagnosis, management, pathomechanisms, possible future treatments and prevention. This paper summarises the discussion and its conclusions.

gastroenterology & hepatology
Invited Sessions at ACPA's 2024 Annual Meeting

DOI: https://doi.org/10.1177/10556656241234521

2024-03-30

The Cleft Palate-Craniofacial Journal

Abstract:The Cleft Palate Craniofacial Journal, Volume 61, Issue 5_suppl, Page S1-S171, May 2024.

dentistry, oral surgery & medicine,surgery
Behavioral economic and wellness-based approaches for reducing alcohol use and consequences among diverse non-student emerging adults: study protocol for Project BLUE, a randomized controlled trial

James G. Murphy,Ashley A. Dennhardt,Jacob Tempchin,Hannah E. Colgonis,Meghan E. McDevitt-Murphy,Brian Borsari,Kristoffer S. Berlin,Brian Borsari and Kristoffer S. Berlin

DOI: https://doi.org/10.1186/s13063-024-08009-9

IF: 2.728

2024-03-11

Trials

Abstract:Emerging adults (EAs) who are not 4-year college students nor graduates are at elevated risk for lifetime alcohol use disorder, comorbid drug use, and mental health symptoms, compared to college graduates. There is a need for tailored brief alcohol intervention (BAI) approaches to reduce alcohol risk and to facilitate healthy development in this high-risk population. Most BAIs include a single session focused on discussing risks associated with drinking and correcting normative beliefs about drinking rates. EAs may benefit from additional elements that enhance general wellness. The substance-free activity session (SFAS) aims to clarify life goals and values and increase goal-directed activities that provide alternatives to alcohol use, and the relaxation training (RT) session teaches relaxation and stress reduction skills.

medicine, research & experimental
Examining the Impact of Simultaneous Alcohol and Cannabis Use on Alcohol Consumption and Consequences: Protocol for an Observational Ambulatory Assessment Study in Young Adults

Rachel L Gunn,Jane Metrik,Nancy P Barnett,Kristina M Jackson,Sharon Lipperman-Kreda,Robert Miranda Jr,Timothy J Trull,Mary Ellen Fernandez

DOI: https://doi.org/10.2196/58685

2024-09-25

Abstract:Background: There is significant conflicting evidence as to how using cannabis while drinking alcohol (ie, simultaneous alcohol and cannabis use) impacts alcohol volume consumed, patterns of drinking, and alcohol-related consequences. The impact of simultaneous use on drinking outcomes may be influenced by several within-person (eg, contextual) and between-person (individual) factors. Objective: This study was designed to examine naturalistic patterns of alcohol and cannabis use to understand how simultaneous use may impact drinking outcomes. The primary aims were to understand the following: (1) if simultaneous use is associated with increased alcohol consumption and riskier patterns of drinking, (2) if simultaneous use leads to increased alcohol consequences, and (3) how contextual circumstances moderate the impact of simultaneous use on consumption and consequences. Methods: Data collection involves a 28-day ambulatory assessment protocol in which a sample of non-treatment-seeking young adults who report simultaneous use of alcohol and cannabis complete ecological momentary assessments (random, event-contingent, and time-contingent surveys) of alcohol and cannabis use, contexts, motives, and consequences on their personal smartphones while continuously wearing an alcohol biosensor bracelet. Participants also complete a baseline assessment, brief internet-based check-in on day 14, and a final session on day 28. Community-based recruitment strategies (eg, social media and flyers) were used to enroll 95 participants to obtain a target sample of 80, accounting for attrition. Results: Recruitment and data collection began in May 2021 and continued through June 2024. Initial results for primary aims are expected in October 2024. As of March 2024, the project had recruited 118 eligible participants, of whom 94 (79.7%) completed the study, exceeding initial projections for the study time frame. Remaining recruitment will provide the capacity to probe cross-level interactions that were not initially statistically powered. Strengths of the project include rigorous data collection, good retention and compliance rates, faster-than-expected enrollment procedures, use of a novel alcohol biosensor, and successful adaptation of recruitment and data collection procedures during the COVID-19 pandemic. Conclusions: This is the first investigation to assess the key momentary predictors and outcomes of simultaneous use as well as self-reported and objective (via alcohol biosensor) measures of alcohol consumption and patterns. The results of this study will inform prevention efforts and studies of individuals who use cannabis who are engaged in alcohol treatment. International registered report identifier (irrid): DERR1-10.2196/58685.

47th Annual RSA Scientific Meeting: June 22–26, 2024, Minneapolis, MN

Texas Research Society On Alcoholism—34Th Annual Scientific Meeting

Summary of poster abstract

Emerging concepts in alcohol, infection & immunity: A summary of the 2023 alcohol and immunology research interest group (AIRIG) meeting

Alcohol and Immunology: Mechanisms of multi-organ damage. Summary of the 2022 alcohol and Immunology research interest group (AIRIG) meeting

Stress-Related Neuropeptides and Alcoholism: Crh, Npy, and Beyond

Abstract LB143: Environmental assessment of alcohol-related policies and practices at US cancer organizations

BASHH Annual Conference 2024, Bournemouth, UK, June 17–19 2024

Proceedings of the 2024 Spring Meeting of the Society of British Neurological Surgeons

Impact of Acute Alcohol Consumption on Sexuality: A Look at Psychological Mechanisms

Proceedings of the 2009 Annual Meeting of the Fetal Alcohol Spectrum Disorders Study Group

S1845 A Cross-Sectional Study of Alcohol Awareness, Consumption Patterns, and Alcohol Related Disease in a Tertiary Center Liver Clinic

Poster abstracts

Proceedings of the 2008 Annual Meeting of the Fetal Alcohol Spectrum Disorders Study Group

68th Annual Meeting of the German Society of Neuropathology and Neuroanatomy (DGNN) - Meeting Abstracts: September 12-14, 2024, Regensburg, Germany

From AACR 2024

Participant diversity in ACER: 2010–2022

Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting

Invited Sessions at ACPA's 2024 Annual Meeting

Behavioral economic and wellness-based approaches for reducing alcohol use and consequences among diverse non-student emerging adults: study protocol for Project BLUE, a randomized controlled trial

Examining the Impact of Simultaneous Alcohol and Cannabis Use on Alcohol Consumption and Consequences: Protocol for an Observational Ambulatory Assessment Study in Young Adults